Nasdaq Stockholm has decided that Meda Aktiebolag (publ) will be delisted from Nasdaq Stockholm. The last trading day of the shares will be Tuesday, August 23, 2016.
Solna, Sweden, August 2016
The board of directors
Meda AB (publ)
For further inquiries, please contact:
This information is information that Meda AB is obliged to make public pursuant to the EU Market Abuse Regulation. The above information was submitted for publication, through the agency of the contact person set out above, 17:15 p.m. CET on 8 August 2016.
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.